1. Balkwill FR (1989) Peptide regulatory factors-Interferons. Lancet 1: 1060?1063
2. Boon T, Coulie P, Marchand M, Weynants P, Wölfel T, Brichard V (1994) Genes coding for tumor rejection antigens: perspectives for specific immunotherapy. In: De Vita VT, Hellman S, Rosenberg SA (eds) Important advances in oncology 1994. Lippincott, Philadelphia, pp 53?69
3. Bubenik J (1993) IL-2 and gene therapy of cancer (review) Int J Oncol 2: 1049?1052
4. Cassel WA, Murray DR, Phillips HS (1983) A phase II study on the postsurgical management of stage II malignant melanoma with a Newcastle disease virus oncolysate. Cancer 52: 856?860
5. Csatary LK, Eckhardt S, et al (1993) Attenuated veterinary virus vaccine for the treatment of cancer. Cancer Detect Prevent 17: 619?627